A prospective study of the long-term efficacy and toxicity of low-dose methotrexate in rheumatoid arthritis.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Clinical and Experimental Rheumatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 7774099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term experience with low dose methotrexate in rheumatoid arthritis

  2004cited by this paper
• Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate.

  1994cited by this paper
• The Chronic Arthritis Systemic Index (CASI).

  1994cited by this paper
• Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months.

  1992cited by this paper
• Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases.

  1992cited by this paper
• Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update.

  1992cited by this paper
• Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases.

  1991cited by this paper
• Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.

  1990cited by this paper
• Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression.

  1989cited by this paper
• Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment.

  1989cited by this paper
• Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis.

  1988cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis.

  1988cited by this paper
• Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study.

  1987cited by this paper
• Pneumonitis during low-dose methotrexate therapy.

  1986cited by this paper
• Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.

  1985cited by this paper
• A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis.

  1984cited by this paper
• Toxicity from methotrexate may be dose related.

  1983cited by this paper
• Frequency of malignant neoplasms in 248 long-term methotrexate-treated psoriatics. A preliminary study.

  1983cited by this paper
• Preliminary criteria for clinical remission in rheumatoid arthritis.

  1981cited by this paper
• Measurement of patient outcome in arthritis.

  1980cited by this paper
• Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

  1968cited by this paper
• Therapeutic criteria in rheumatoid arthritis.

  1949cited by this paper

• Long-term persistence of oral methotrexate and associated factors in rheumatoid arthritis: a retrospective cohort study

  2023cites this paper
• Therapeutic Maintenance Level of Methotrexate in Rheumatoid Arthritis: A RBSMR Study

  2022cites this paper
• Neutropenia in the Elderly: A Rheumatology Perspective

  2016cites this paper
• Adherence and Persistence with Methotrexate in Rheumatoid Arthritis: A Systematic Review

  2016cites this paper
• Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial

  2015cites this paper
• Rheumatoid arthritis: early treatment with corticosteroids and nonsteroidal anti-inflammatory drugs.

  2014cites this paper
• Large ulceration of the oropharynx induced by methotrexate-associated lymphoproliferative disorders.

  2013cites this paper
• [Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice].

  2011cites this paper
• Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).

  2011cites this paper
• Prevention of methotrexate chemotherapy-induced bone growth arrest and osteoporosis with folinic acid.

  2011cites this paper
• NÓDULOS AURICULARES ULCERADOS SIMÉTRICOS

  2008cites this paper
• Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research

  2008cites this paper
• CORRELATIVO CLÍNICO PATOLÓGICO

  2007cites this paper
• Rheumatoid nodule.

  2007cites this paper
• Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results

  2007cites this paper
• Fix-sequenzielle Folsäuresupplementierung bei Methotrexat-Therapie

  2005cites this paper
• Duration of rheumatoid arthritis influences the degree of functional improvement in clinical trials

  2005cites this paper
• Oral effects of low-dose methotrexate treatment.

  2005cites this paper
• Rheumatoid arthritis: a review of the cutaneous manifestations.

  2005cites this paper
• Pilot studies: one swallow does not make a summer...

  2003cites this paper
• Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients.

  2001cites this paper
• Are There Differences in Methotrexate Kinetics Between Responding and Nonresponding Patients with Rheumatoid Arthritis?

  2000cites this paper
• Discriminating ability of composite indices for measuring disease activity in rheumatoid arthritis: a comparison of the Chronic Arthritis Systemic Index, Disease Activity Score and Thompson's articular index.

  2000cites this paper
• Effects of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) alone and in combination with methotrexate in adjuvant arthritic rats.

  1999cites this paper
• Accelerated nodulosis during methotrexate therapy for refractory rheumatoid arthritis. A case report.

  1999cites this paper
• Radiologic progression in early rheumatoid arthritis treated with methotrexate.

  1999cites this paper
• Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.

  1999cites this paper
• Changing patterns in the use of slow acting antirheumatic drugs for the treatment of rheumatoid arthritis.

  1998cites this paper
• Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity.

  1998cites this paper
• Importance of psychological well being and disease activity in termination of an initial DMARD therapy.

  1997cites this paper
• Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: Report of five cases and review of the literature

  1997cites this paper
• Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate: an open, retrospective, observational study.

  1997cites this paper
• Methotrexate in Rheumatoid Arthritis

  1997cites this paper
• Association of methotrexate and corticosteroids in the treatment of patients with rheumatoid arthritis.

  1996cites this paper
• Combination therapy of cyclosporine A with methotrexate or hydroxychloroquine in refractory rheumatoid arthritis.

  1996cites this paper
• Three-year prospective study on methotrexate in rheumatoid arthritis. Analysis of radiological progression and comparison with a retrospective study.

  1996cites this paper
• Do Nonsteroidal Anti-Inflammatory Drugs Have a Protective Effect Against Dementia?

  1996cites this paper
• Use of Methotrexate in Older Patients

  1996cites this paper